HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

zedoarondiol

structure in first source

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Terpenes: 1461
    - Sesquiterpenes: 1370
      - zedoarondiol: 3
- Lactones: 1549
  - zedoarondiol: 3

Experts

1.	Shi, Dazhuo: 3 articles (01/2022 - 01/2016)
2.	Liu, Mi: 2 articles (01/2018 - 01/2016)
3.	Liu, Xiuhua: 2 articles (01/2018 - 01/2016)
4.	Mao, Huimin: 2 articles (01/2018 - 01/2016)
5.	Song, Dandan: 2 articles (01/2018 - 01/2016)
6.	Tao, Tianqi: 2 articles (01/2018 - 01/2016)
7.	Wang, Xiaoren: 2 articles (01/2018 - 01/2016)
8.	Chai, Hua: 1 article (01/2022)
9.	He, Shan: 1 article (01/2022)
10.	Huang, Hongbo: 1 article (01/2022)

Related Diseases

1.	Atherosclerosis 01/01/2022 - "Zedoarondiol inhibits atherosclerosis by regulating monocyte migration and adhesion via CXCL12/CXCR4 pathway." 01/01/2016 - "These findings suggest that zedoarondiol might be a promising compound against atherosclerosis and in-stent restenosis." 01/01/2018 - "Zedoarondiol attenuates ox-LDL-induced endothelial cells injury by inhibiting oxidative stress and inflammation via Nrf2/HO-1 pathway, suggesting that zedoarondiol might be meaningful on prevention and treatment of atherosclerosis."
2.	Inflammation (Inflammations) 01/01/2018 - "Zedoarondiol attenuates ox-LDL-induced endothelial cells injury by inhibiting oxidative stress and inflammation via Nrf2/HO-1 pathway, suggesting that zedoarondiol might be meaningful on prevention and treatment of atherosclerosis."

Related Drugs and Biologics

1.	oxidized low density lipoprotein

Related Therapies and Procedures

1.	Stents